Search
for
Sort by
Research 31–60 of 44
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Recent advances on skin‐resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti‐aging and cancer therapies
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review)
- Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth? - eScholarship
- The citrullinating enzyme PADI4 governs progenitor cell proliferation and translation in developing hair follicles
- Generation of the Krt24-CreERT2 Mouse Line Targeting Outer Bulge Hair Follicle Cells
- Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth Factor
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)
- Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib
- Acneiform eruptions caused by an epidermal growth factor receptor-tyrosine kinase inhibitor ZD 1839
- [ADAPTIVE REGULATORY MECHANISMS OF ALOPECIA AREATA].
- Alopecia Areata
- 5-Alpha-Reductase Inhibitors in the Treatment of Male Androgenetic Alopecia: Clinical Experience
- Clinical guidelines of ukrainian hair research society. diagnosis and treatment of alopecia areata
- RELAÇÃO ENTRE A COVID-19 E A DOENÇA DE KAWASAKI EM INFANTES
- Cosmeceutical Applications of Phlorotannins from Brown Seaweeds
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System